A Double-blind, Placebo Controlled, Randomised Trial to Compare the Efficacy of 250ng and 500ng RN1006 (a New Formulation of Avotermin) and 250ng and 500ng Juvista (Standard Avotermin Formulation), in the Improvement of Scar Appearance in Healthy Volunteer Subjects
Latest Information Update: 20 May 2014
At a glance
- Drugs Avotermin (Primary)
- Indications Scars
- Focus Therapeutic Use
- Sponsors Renovo
Most Recent Events
- 20 May 2014 New trial record